(MENAFN- GlobeNewsWire - Nasdaq) PARIS and CAMBRIDGE, Mass., Nov. 09, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the“Company”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that Company management will participate in the following investor conferences in November: Jefferies Global Healthcare Conference in London
Date: Monday, November 16, 2026
Presentation Time: 8:30am ET / 1:30pm GMT
Location: London (UK)
Presenters: Laurent Levy, Chief Executive Officer and Arnd Christ, Chief Financial Officer
UBS Global Biopharma Conference
Date: Tuesday, November 17, 2026
Location: London (UK)
About NANOBIOTIX
Nanobiotix is a late-stage clinical biotechnology company pioneering disruptive, physics-based therapeutic approaches to revolutionize treatment outcomes for millions of patients; supported by people committed to making a difference for humanity. The Company's philosophy is rooted in the concept of pushing past the boundaries of what is known to expand possibilities for human life.
Incorporated in 2003, Nanobiotix is headquartered in Paris, France and is listed on Euronext Paris since 2012 and on the Nasdaq Global Select Market in New York City since December 2020. The Company has subsidiaries in Cambridge, Massachusetts (United States) amongst other locations.
Nanobiotix is the owner of more than 30 umbrella patents associated with three (3) nanotechnology platforms with applications in 1) oncology; 2) bioavailability and biodistribution; and 3) disorders of the central nervous system.
For more information about Nanobiotix, visit us at or follow us on LinkedIn and Twitter .
| Nanobiotix | |
Communications Department
Brandon Owens
VP, Communications
+1 (617) 852-4835
... |
Investor Relations Department
Joanne Choi
VP, Investor Relations (US)
...
Ricky Bhajun
Director, Investor Relations (EU)
+33 (0) 79 97 29 99
...
| |
| Media Relations | |
France – HARDY
Caroline Hardy
+33 06 70 33 49 50
... |
Global – uncapped
Becky Lauer
+1 (646) 286-0057
... | |
Attachment
PR-20261109-November_Conference_Participation_2026
MENAFN09112026004107003653ID1111936944
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment